BOSTON--(BUSINESS WIRE)--The Food Allergy Science Initiative, Inc. (FASI) is thrilled to announce a prestigious Program Project Grant (P01) from the National Institutes of Health’s, National Institute ...

Up to $2 million in grant funding may be provided by NIAID to support DARE-HPV development, bringing total non-dilutive funding for DARE-HPV advancement to up to $12 million SAN DIEGO, Feb. 06, 2025 ...

South Korean biotech startup HTnB Inc. said Tuesday it has partnered with U.S. federal agencies to develop a next-generation medical countermeasure for radiation exposure. HTnB signed a non-clinical ...

Jaguar intends to pursue a Tropical Disease Priority Review Voucher, under FDA's financial incentive program, to develop NP-300 for this indication SAN FRANCISCO, CA / ACCESSWIRE / September 12, 2023 ...

NORTH BRUNSWICK, N.J.--(BUSINESS WIRE)--Lactiga, a biotech company leading the development of naturally-occurring antibody therapies for inflammatory and immunodeficient conditions, has been awarded a ...

NIH/National Institute of Allergies and Infectious Disease (NIAID) is part of the National Institute of Health, funded through theUSA Department of Health and Human Services, a cabinet level agency.

Approximately 1 in 30 trials were disrupted by research grant terminations at the National Institutes of Health (NIH) earlier this year, with infectious disease studies impacted most, affecting more ...

Jonathan Wosen is STAT’s West Coast biotech & life sciences reporter. You can reach Jonathan on Signal at jwosen.27. The National Institutes of Health on Friday announced six acting directors to run ...

The rapid adoption of chatbots such as ChatGPT in mainstream society have placed artificial intelligence (AI) front and centre of the public debate on science in the past two years. Consequently, ...